Summary & Overview
CPT 27616: Extensive Soft Tissue Tumor Resection, Leg or Ankle ≥5 cm
CPT code 27616 describes the extensive surgical excision of a soft tissue tumor in the leg or ankle measuring 5 cm or larger. This code captures higher-complexity oncologic and reconstructive work on the lower extremity and is used in procedural reporting for major soft tissue tumor resections. Nationally, accurate coding for large soft tissue tumor excisions affects procedure-level case mix, hospital resource allocation, and specialty surgical revenue streams.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical procedure and typical sites of service, an outline of common modifiers and billing considerations, and what to expect in terms of coding placement when documenting extensive lower-extremity tumor resections. The publication also highlights benchmarking topics and policy implications relevant to high-complexity surgical oncology billing. The content is intended to inform coding professionals, surgical practices, revenue cycle teams, and policy stakeholders about the clinical context and billing role of CPT code 27616.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and payer-specific reimbursement benchmarks.
Billing Code Overview
CPT code 27616 describes extensive surgical removal of a soft tissue tumor and surrounding tissues of the leg or ankle area measuring 5 cm or more. This procedure involves excision of a large soft tissue neoplasm located on the leg or ankle, including resection of adjacent involved soft tissues to achieve adequate margins.
-
Service type: Surgical excision of a large soft tissue tumor (extensive soft tissue tumor resection)
-
Typical site of service: Hospital operating room or ambulatory surgical center for lower extremity (leg or ankle) soft tissue tumor resection
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents with a progressively enlarging, palpable soft-tissue mass of the distal lower extremity involving the leg/ankle region. Imaging (MRI) demonstrates a deep, >5 cm soft-tissue tumor abutting surrounding musculature and neurovascular structures without clear signs of distant metastasis. Core needle biopsy returns a diagnosis consistent with a soft-tissue sarcoma. The surgical oncology or orthopaedic oncology team schedules an operative procedure for wide local excision of the tumor with appropriate margins, planned reconstruction as needed, intraoperative frozen section evaluation, and potential split-thickness skin graft or local flap coverage.
Preoperative workflow includes surgical consent, review of imaging, multidisciplinary tumor board discussion when indicated, anesthesia evaluation, and marking of operative site. Intraoperative steps include tumor resection measuring ≥5 cm using CPT 27616, intraoperative pathology consultation for margin assessment, hemostasis, and soft-tissue reconstruction or wound coverage. Postoperative care involves inpatient monitoring for vascular or wound complications, pain control, physical therapy for limb function, and pathology review to determine need for adjuvant radiation or chemotherapy. Typical sites of service are an ambulatory surgery center for straightforward resections or an inpatient hospital operating room for extensive resections requiring reconstruction or expected postoperative monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|